FDA Approves Expanded Use of Nivolumab for Lung Cancer October 9, 2015December 14, 2022 Matthew Tontonoz
FDA Approves PD-1 Immunotherapy for Most Common Type of Lung Cancer October 2, 2015December 14, 2022 Matthew Tontonoz
In a First, FDA Approves Immunotherapy Combination for Advanced Melanoma October 1, 2015December 14, 2022 Matthew Tontonoz
European Regulators Approve Pembrolizumab (Keytruda) as First-line Treatment of Advanced Melanoma July 22, 2015December 14, 2022 Matthew Tontonoz
What Cancer Patients Need to Know About the Opdivo Approval March 13, 2015December 14, 2022 Emily Helck
Big News: FDA Approves Opdivo (Nivolumab) for Lung Cancer March 4, 2015December 14, 2022 Matthew Tontonoz
